Ahmedabad: Managing Director of Zydus Dr. Sharvil Patel today said: The clinical trial phase of Zydus vaccine against Covid19 is over. Our vaccine had largest clinical study on Indian population covering over 28,000 patients. We have covered all groups including those above 60-75 years age, comorbid young ones and even 12-18 years children. We expect efficacy results to be out in the month of May this year and then we will apply with DCGI for emergency use approval. We have given lot of data to...Read More

Ahmedabad: Managing Director of Zydus Cadila today said company's upcoming Virafin medicine will be out in ten days for selective covid treating facility. It will be available in large number for wider consumption after 45 days. On Virafin: Virafin is interferon injection which is known as anti viral drug. Worldwide it has been used for hepatitis B, hepatitis C and other viruses. It neutralizes virus and prevent its replication and helps the body for viral clearance. Its single dose has to...Read More